http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0013924-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
filingDate 2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9eff3d1814f712b647fa0c6727288f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9647957104688f813322128f09f18fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f087f103e5d78033d845a7c26837c3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17090e6f59957f872448aaae172e7a3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff84c2fd51ff2c61635a0c2b96da749b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a0a6b30700682e0e130ab24799d8691
publicationDate 2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0013924-A
titleOfInvention Levosimendan pharmaceutical solutions
abstract "LEVOSIMENDAN PHARMACEUTICAL SOLUTIONS". The invention relates to levosimendan solutions for pharmaceutical use, and particularly for intravenous administration. The solutions of the invention have increased stability and are particularly useful as injection or infusion solutions or infusion concentrates. Levosimendan is useful in the treatment of congestive heart failure.
priorityDate 1999-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033825

Total number of triples: 29.